Furthermore, studies have shown that genetic deletion of CCL2 (Hughes et al., 2002) and CCR2 (Dimitrijevic et al., 2007) reduces BBB permeability, accumulation of immune cells in ischemic brain tissue, and subsequent cerebral infarction (Chu et al., 2014). Here, CCL2 is linked to cerebral infarction.